The Beauty Health Company (SKIN) Misses Q3 EPS by 6c ; Offers Guidance

The Beauty Health Company (NASDAQ: SKIN) reported Q3 EPS of ($0.15), $0.06 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $78.8 million versus the consensus estimate of $73.8 million.

GUIDANCE:

The Beauty Health Company sees FY2024 revenue of $322-332 million, versus the consensus of $341.1 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Gates Industrial launches three new bicycle belt drive sprocket families
• 8x8 reports data breach via third-party Salesforce integration